- Discover
- /
- SYRS
Sagehood
Financial Analyst
PREMIUM
Technical Trader
PREMIUM
Valuation Projection
PREMIUM
Social Media Buzz
PREMIUM
News Agent
PREMIUM
Macro Economist
PREMIUM
About SYRS
8/25/2025
Comprehensive Analysis
Financial Health
- Balance Sheet Deterioration: SYRS’s equity turned negative in Q3 2024 (-$11.1M), with total assets collapsing from $168.2M to $85.0M. The current ratio (2.25) remains adequate short-term, but a debt-to-equity ratio of 2.75 and negative net income (-$97.8M TTM) signal severe solvency risks.
Free Insights for Smarter Investing
Get 5 daily AI-powered insights on your favorite stocks-absolutely free.
Free Account
- View 5 tickers daily
- Create and manage Watchlists
- Import portfolios (no personalized insights)
- Chat with the general Sagehood AI Agent
- Market Radar: Preview access only
Premium Membership
- Unlimited AI-generated insights across all sections
- Market Overview
- Market Radar (AI-driven investment opportunities)
- Access to all Sagehood AI agents, including domain-specific experts
- Personalized insights and actionable recommendations for smarter investing